Beyond early research, the artificial intelligence (AI) in pharmaceutical market is increasingly tied to clinical development and underserved therapeutic areas. Polaris Market Research values the market at USD 2.48 billion in 2025 and projects USD 28.63 billion by 2034, a CAGR of 31.2% from 2026 to 2034. This article focuses on where AI can improve trial execution, expand research into complex...